DK0440341T3 - EFA præparater og anvendelsen heraf - Google Patents

EFA præparater og anvendelsen heraf

Info

Publication number
DK0440341T3
DK0440341T3 DK91300234.1T DK91300234T DK0440341T3 DK 0440341 T3 DK0440341 T3 DK 0440341T3 DK 91300234 T DK91300234 T DK 91300234T DK 0440341 T3 DK0440341 T3 DK 0440341T3
Authority
DK
Denmark
Prior art keywords
efa
preparations
bioavailable
dgla
gla
Prior art date
Application number
DK91300234.1T
Other languages
Danish (da)
English (en)
Inventor
David Frederick Horrobin
Frank Corrigan
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Application granted granted Critical
Publication of DK0440341T3 publication Critical patent/DK0440341T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91300234.1T 1990-01-18 1991-01-14 EFA præparater og anvendelsen heraf DK0440341T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909001121A GB9001121D0 (en) 1990-01-18 1990-01-18 Efa compositions and therapy

Publications (1)

Publication Number Publication Date
DK0440341T3 true DK0440341T3 (da) 1994-02-14

Family

ID=10669492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91300234.1T DK0440341T3 (da) 1990-01-18 1991-01-14 EFA præparater og anvendelsen heraf

Country Status (14)

Country Link
US (1) US5116624A (ja)
EP (1) EP0440341B1 (ja)
JP (1) JP3008213B2 (ja)
AT (1) ATE98125T1 (ja)
AU (1) AU638525B2 (ja)
CA (1) CA2033823C (ja)
DE (1) DE69100724T2 (ja)
DK (1) DK0440341T3 (ja)
ES (1) ES2060290T3 (ja)
GB (1) GB9001121D0 (ja)
HK (1) HK74994A (ja)
IE (1) IE67622B1 (ja)
NZ (1) NZ236744A (ja)
ZA (1) ZA91183B (ja)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
WO1993016708A1 (en) * 1992-02-19 1993-09-02 Colby Corporation Limited Pharmaceutical compositions and their use for treating zinc deficient disorders
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
ATE196844T1 (de) * 1996-05-22 2000-10-15 Protarga Inc Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
AU731692C (en) * 1996-10-11 2001-10-11 Scarista Limited Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
WO1998048788A1 (en) * 1997-04-29 1998-11-05 Scotia Holdings Plc Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
US6197764B1 (en) 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
FR2774596B1 (fr) * 1998-02-11 2000-03-17 Rhone Poulenc Rorer Sa Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US7112609B2 (en) * 1999-06-01 2006-09-26 Drugtech Corporation Nutritional supplements
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
ES2387562T3 (es) * 2001-03-23 2012-09-26 Luitpold Pharmaceuticals, Inc. Conjugados alcohol graso-medicamento
EP1427407A4 (en) * 2001-03-23 2005-05-11 Luitpold Pharm Inc CONJUGATES BASED ON FATTY AMINES AND PHARMACEUTICAL AGENTS
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
DE10305138A1 (de) * 2003-02-07 2004-08-26 Axxima Pharmaceuticals Ag Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen
US20060292217A1 (en) * 2005-06-03 2006-12-28 Schmidt Robbin D Nutritional supplement and soft gelatin capsule delivery system
NZ540958A (en) 2005-06-27 2007-11-30 Agres Ltd Veterinary formulation for injectable administration of selenomethionine for production of selenium-rich foods
US8871715B2 (en) * 2005-10-14 2014-10-28 Alltech, Inc. Use of selenium compounds, especially selenium yeasts for altering cognitive function
US20080004255A1 (en) * 2005-10-14 2008-01-03 Alltech, Inc. Methods and compositions for altering cell function
US8865763B2 (en) * 2005-10-14 2014-10-21 Alltech, Inc. Methods and compositions for altering cell function
TWI319708B (en) * 2005-10-14 2010-01-21 Methods and compositions for altering cell fuction
US20100247679A1 (en) * 2006-04-24 2010-09-30 Alltech, Inc. Methods and compositions for altering cell function
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA2704371A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
WO2009133586A1 (ja) * 2008-04-28 2009-11-05 有限会社アンティアンティ アルツハイマー病の治療医薬
EP2627330A2 (en) * 2010-10-12 2013-08-21 Vifor SA Novel omega-3 and omega-6 fatty acid compositions and uses thereof
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US8715648B2 (en) 2011-02-16 2014-05-06 Pivotal Therapeutics Inc. Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
JP2016023163A (ja) * 2014-07-22 2016-02-08 出光興産株式会社 γ−リノレン酸を含む神経細胞の酸化ストレス軽減剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1082624A (en) 1965-02-26 1967-09-06 Calmic Ltd Improvements in or relating to therapeutically active compounds
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
IE47777B1 (en) 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
HU204199B (en) * 1987-03-18 1991-12-30 Caola Kozmetikai Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components
ES2032844T3 (es) * 1987-07-09 1993-03-01 Pierre Moreau Nuevos composiciones ricas en oligoelementos y sus procedimientos de fabricacion.

Also Published As

Publication number Publication date
NZ236744A (en) 1993-03-26
CA2033823A1 (en) 1991-07-19
HK74994A (en) 1994-08-05
GB9001121D0 (en) 1990-03-21
JP3008213B2 (ja) 2000-02-14
ATE98125T1 (de) 1993-12-15
DE69100724D1 (de) 1994-01-20
IE910050A1 (en) 1991-07-31
JPH0733655A (ja) 1995-02-03
CA2033823C (en) 2002-04-09
ES2060290T3 (es) 1994-11-16
EP0440341A1 (en) 1991-08-07
ZA91183B (en) 1991-10-30
DE69100724T2 (de) 1994-04-28
US5116624A (en) 1992-05-26
EP0440341B1 (en) 1993-12-08
AU6925691A (en) 1991-07-25
AU638525B2 (en) 1993-07-01
IE67622B1 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
DK0440341T3 (da) EFA præparater og anvendelsen heraf
AU2206188A (en) Azithromycin and derivatives as antiprotozoal agents
MX9203403A (es) Carboxilatos heterociclicos 17-aromaticos de 3,20-dioxo-1,4-pregnadieno 17&-ol.
AU612172B2 (en) 5-amino or substituted amino 1,2,3-triazoles useful as antiproliferative agents
IT7926970A0 (it) Mezzi per l'attivazione e la disattivazione di innesti.
GB2236028B (en) Field effect transistor amplifier
IT1227849B (it) Composizione per l'igiene orale.
ES2037073T3 (es) Un producto para el cuidado de la boca.
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
DE69116321D1 (de) Immunostimulierendes Mittel das Interleukin-2 und 5'-Deoxy-5-fluorouridin enthält
ATE69235T1 (de) Erythromycin-a-derivate, modifiziert in position- c-12.
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
IT1224636B (it) Esteri penem 6 sostituiti come agenti antinfiammatori e antidegenerativi.
DE59003130D1 (de) Mikrobizid-Formulierungen und deren Verwendung.
CA1265159C (en) GEM-DIHALOGENO-1,8-DIAMINO-4-AZA-OCTANES
GR3017749T3 (en) Novel antibiotic compounds and their production.
IT1239236B (it) Motorullo per l'azionamento di nastri trasportatori
EP0211490A3 (en) Antibiotics of the vancomycin-class
ZA901320B (en) Compositions for the treatment of microbial infections
KR920013331U (ko) 아이들러(idler)의 2단 구동장치
IE871913L (en) 1,3-propanediamine derivatives
GR3000898T3 (en) Triazine derivative, its preparation and use
ES266269Y (es) "clasificador de frutos perfeccionado".
LT2027B (lt) Bakteriju escherichia coli kamienas-restriktazes cfr10 1 producentas
CA1265160C (en) GEM-DIHALOGENO- AND GEM-TETRAHALOGENO-1,12-DIAMINO-4,9-DIAZA-DODECANE